This workshop explores the critical intersection of industrial bioprocessing and academic innovation in the stem cell field. We begin by addressing the industrial landscape, focusing on key considerations and challenges in scalable manufacturing. From maintaining raw material consistency to implementing automated expansion protocols, this segment outlines the rigorous frameworks required to transition from laboratory-scale protocols to commercial-grade production. Building on these foundational manufacturing strategies, the session then examines the next generation of stem cell-based replacement therapies. We will discuss how advanced bioprocessing enables the translation of complex iPSC research into viable clinical candidates. By prioritizing scalability and quality control early in the development cycle, researchers can better navigate the logistical bottlenecks of therapeutic translation. Participants will gain a comprehensive overview of the roadmap from cell line engineering to large-scale manufacturing, ensuring that the future of regenerative medicine is both scientifically sound and industrially feasible.

12:30 PM - 01:30 PM

Sponsored by: ACROBiosystems